1173656-67-1

Basic information

• Product Name: 7-bromo-2,3-dimethylimidazo[1,2-a]pyridine
• Synonyms: 7-bromo-2,3-dimethylimidazo[1,2-a]pyridine;NGAOEMUZGCDAHO-UHFFFAOYSA-N
• CAS NO: 1173656-67-1
• Molecular Formula: C₉H₉BrN₂
• Molecular Weight: 225.08516
• Mol File: 1173656-67-1.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 7-bromo-2,3-dimethylimidazo[1,2-a]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 7-bromo-2,3-dimethylimidazo[1,2-a]pyridine(1173656-67-1)
• EPA Substance Registry System: 7-bromo-2,3-dimethylimidazo[1,2-a]pyridine(1173656-67-1)

Safety Data

• Hazardous Substances Data: 1173656-67-1(Hazardous Substances Data)

Upstream product

• 84249-14-9 2-amino-4-bromopyridine 
• 814-75-5 3-bromo-butanone 

Downstream Products

• 1173656-65-9 N-(2,3-dimethylimidazo[1,2-a]pyrid-7-yl)-5-fluoro-1-[(3-fluorophenyl)methyl]-1H-indole-2-carboxamide 

Relevant articles and documents

SUBSTITUTED HETEROARYL COMPOUNDS AND METHODS OF USE

The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.

N-AZABICYCLIC CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF

This disclosure relates to compounds of formula (I): wherein X1, X2, X3, X4, n, Y, W, and A are as defined in the disclosure, or a salt thereof, or a hydrate or solvate thereof, and to processes for the preparation of these compounds and the therapeutic use thereof.